Abstract:High quality performance is important to prevent colorectal cancers (CRCs) after colonoscopy. Therefore, we endoscopists are measured every day on our rates of cecal intubation, detection of polyps and adenomas, and patient satisfaction. That is great, and we support it. It helps us to understand our own performance in comparison to our peers, increases patient benefits, and reduces harms. After all, our endoscopies are there for the benefit of the people we treat: our patients. Occasionally, a patient who we have recently scoped gets cancer. This is not good, but it is inevitable because first the risk of cancer after colonoscopy can never be zero and second sometimes the cancer is not causally related to the performance of the colonoscopy (although good quality reduces the risk). Thanks to the modern endoscopy quality improvement systems we have set up, many endoscopy services are now able to track a CRC developing after a colonoscopy back to the colonoscopy that one of us performed some time prior to the diagnosis. The question is: how do we learn from such unwanted events to prevent them in the future? The current issue of Endoscopy features a study that sheds light on this important question by disentangling the reasons for CRCs after colonoscopy [1]. The study empaneled data from the nationwide CRC screening program in the Netherlands and constructed a cohort of patients who were diagnosed with CRC within about 5 years of their colonoscopy for a positive FIT screening test between 2014 and 2016 [1]. Out of over 116000 patients who were scoped after a positive FIT, 432 patients were diagnosed with CRC a median of 31 months after the colonoscopy (CRC diagnoses in the first 6 months after the colonoscopy were not included – this is common and well reasoned in studies of CRC after colonoscopy). "... the abbreviation PCCRC should be abandoned...I suggest keeping it simple and in line with what other fields in medicine are using, for instance the term "interval cancer" is well established..." The researchers followed guidance from the World Endoscopy Organization (WEO) and categorized the cancers into four types [2]: cancers diagnosed before the date of the recommended surveillance colonoscopy cancers diagnosed at the recommended surveillance colonoscopy cancers diagnosed after the recommended surveillance colonoscopy cancers diagnosed after the recommended surveillance colonoscopy in patients where surveillance was not performed owing to co-morbidity. The WEO guidance document terms the first category "interval post-colonoscopy CRC" (PCCRC), and the three others "non-interval PCCRC." Most cancers in the Dutch study (52%) were in the first category. The most important part of the Dutch study is the thoroughly performed root-cause analysis of each cancer. It indicates that 74% of all cancers diagnosed before the date of the recommended surveillance colonoscopy are likely due to overlooked lesions. Incomplete removal or polyps not being removed were common reasons for the other cancer types, but the numbers were small and there is uncertainty around the observed point estimates. The findings of this new study are consistent with other recent evidence that many interval cancers are avoidable. A recent UK cohort found that approximately 70% of cancers after colonoscopy may be due to missed or incompletely removed polyps or lesions [3]. A couple of features in the new Dutch study deserve further consideration. First, the authors report a lower risk of cancer after colonoscopy compared with FIT-screening studies in some other European countries. Whether this is because of different background cancer risks in the populations, different FIT cutoffs in the national screening programs, or better training of endoscopists in the Netherlands is difficult to disentangle. Whether the Dutch results can be translated to colonoscopy screening programs instead of FIT programs is uncertain, but the absolute risks are likely to be smaller owing to the different risk profiles of individuals who undergo colonoscopy in colonoscopy screening programs compared with those within FIT programs. Second, the authors point out that the WEO guidance document requires an update to include possible missed advanced serrated polyps as a reason for interval cancer after colonoscopy. Currently, only for adenomas in the same segment are inferences allowed to be made about the reason for interval cancer in root-cause analyses [2]. Third, caution is warranted when comparing cancer stage for the different types of interval cancer. Because cancers detected at surveillance colonoscopy are detected earlier than clinically symptomatic cancers, such analyses are potentially invalid owing to lead-time bias and likely also overdiagnosis bias. Finally, if one wants to investigate the prognosis of interval cancer after screening, the most valid comparison group is clin -Abstract Truncated-

Clinical and Genomic Characterization of Interval Colorectal Cancer in Three Prospective Cohorts

Evaluating the use of environmental and polygenic risk scores to inform colorectal cancer risk-based surveillance intervals

National and Subnational Incidence, Mortality and Associated Factors of Colorectal Cancer in China: A Systematic Analysis and Modelling Study.

How to learn from interval cancers in colorectal cancer screening

Incidence of colorectal cancer at different screening intervals after index colonoscopy and post-polypectomy: a meta-analysis of 811,181 participants

Analysis of Survival Among Adults With Early-Onset Colorectal Cancer in the National Cancer Database

Lack of association between screening interval and cancer stage in Lynch syndrome may be accounted for by over-diagnosis; a prospective Lynch syndrome database report

Screening Colonoscopy Findings Are Associated With Noncolorectal Cancer Mortality

Effectiveness of colorectal cancer screening integrating non-genetic and genetic risk: a prospective study based on UK Biobank data

Genomic landscape of diploid and aneuploid microsatellite stable early onset colorectal cancer

Risk-stratified screening and colorectal cancer incidence and mortality: A retrospective study from the prostate, lung, colorectal, and ovarian cancer screening trial

Field synopsis of environmental and genetic risk factors of sporadic early-onset colorectal cancer and advanced adenoma.

Genetic landscape of colorectal cancer (CRC) across genetic ancestries: Implications for early cancer detection (ECD).

Comprehensive Genomic Characterization of Sporadic Synchronous Colorectal Cancer: Implications for Treatment Optimization and Clinical Outcome.

Early-Onset Colorectal Cancer in Patients under 50 Years of Age: Demographics, Disease Characteristics, and Survival

Abstract 5873: Distinct Prevalence and Spectrum of Germline Cancer Susceptibility Gene Mutations Between Early-Onset and Late-Onset Colorectal Caner

The genomic landscape of 2,023 colorectal cancers

Prospective Statewide Study of Universal Screening for Hereditary Colorectal Cancer: The Ohio Colorectal Cancer Prevention Initiative

Proportions and characteristics of interval cancer in annual fecal immunochemical test screening and postcolonoscopy colorectal cancer: Results from a Japanese multicenter prospective study using questionnaires, the C‐DETECT study

Interval Cancer in Population-Based Colorectal Screening Programmes: Incidence and Characteristics of Tumours

No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies